Search
Quantum BioPharma Ltd
QNTMAdd to Watchlist
3.610USD
-0.050-1.37%
Close 09-21 16:00（ET）
27.20MMarket Cap
LossP/E TTM
Quantum BioPharma Ltd (QNTM) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Quantum BioPharma Ltd in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.500USD+241.53%
QNTM Analyst Recommendation Trends
In the current month, QNTM has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. QNTM average Analyst price target in the last month is 12.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
QNTM Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
7
7
1
1
21
Financial Forecasting
Based on analysts' estimates, QNTM EPS is projected to reach -0.500 in FY2026Q3, following reported EPS of -0.489 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.22
-0.49
-0.42
-0.50
-0.75
Actual
-0.79
-3.02
-0.49
--
--
Surprise
-259.01%
-516.42%
-16.45%
--
--
FAQs
What is Quantum BioPharma Ltd's expected revenue for the next quarter?
Quantum BioPharma Ltd's expected revenue is 1.45M.
What is Quantum BioPharma Ltd's price target?
Analysts forecast that Quantum BioPharma Ltd's price target is USD 12.50, with the highest forecast at USD 12.50 and the lowest forecast at USD 12.50.
How have Quantum BioPharma LtdQNTM's recent earnings per share performed?
The market expectation was USD -0.49, while Quantum BioPharma LtdQNTM's earnings per share (EPS) for the previous quarter was USD -3.02. EPS for the next quarter is expected at USD -0.50.
What is the analyst rating for Quantum BioPharma Ltd?
Based on the ratings of Quantum BioPharma Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.